Budget impact analysis of increasing prescription of renin-angiotensin system inhibitors drugs to standard anti-hypertensive treatments in patients with diabetes and hypertension in a hypothetical cohort of Malaysian population.

MLA

Mohd-Tahir, Nurul-Ain, and Shu-Chuen Li. “Budget Impact Analysis of Increasing Prescription of Renin-Angiotensin System Inhibitors Drugs to Standard Anti-Hypertensive Treatments in Patients with Diabetes and Hypertension in a Hypothetical Cohort of Malaysian Population.” PLoS ONE, vol. 14, no. 2, Feb. 2019, pp. 1–13. EBSCOhost, https://doi.org/10.1371/journal.pone.0212832.

APA

Mohd-Tahir, N.-A., & Li, S.-C. (2019). Budget impact analysis of increasing prescription of renin-angiotensin system inhibitors drugs to standard anti-hypertensive treatments in patients with diabetes and hypertension in a hypothetical cohort of Malaysian population. PLoS ONE, 14(2), 1–13. https://doi.org/10.1371/journal.pone.0212832

Chicago

Mohd-Tahir, Nurul-Ain, and Shu-Chuen Li. 2019. “Budget Impact Analysis of Increasing Prescription of Renin-Angiotensin System Inhibitors Drugs to Standard Anti-Hypertensive Treatments in Patients with Diabetes and Hypertension in a Hypothetical Cohort of Malaysian Population.” PLoS ONE 14 (2): 1–13. doi:10.1371/journal.pone.0212832.